↓ Skip to main content

Rituximab Followed by Belimumab Controls Severe Lupus Nephritis and Bullous Pemphigoid in Systemic Lupus Erythematosus Refractory to Several Combination Therapies

Overview of attention for article published in Frontiers in Medicine, October 2020
Altmetric Badge

Citations

dimensions_citation
8 Dimensions

Readers on

mendeley
23 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Rituximab Followed by Belimumab Controls Severe Lupus Nephritis and Bullous Pemphigoid in Systemic Lupus Erythematosus Refractory to Several Combination Therapies
Published in
Frontiers in Medicine, October 2020
DOI 10.3389/fmed.2020.553075
Pubmed ID
Authors

Luca Petricca, Maria Rita Gigante, Annamaria Paglionico, Stefano Costanzi, Gisella Vischini, Clara Di Mario, Valentina Varriano, Giacomo Tanti, Barbara Tolusso, Stefano Alivernini, Giuseppe Grandaliano, Gianfranco Ferraccioli, Elisa Gremese

Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 23 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 23 100%

Demographic breakdown

Readers by professional status Count As %
Researcher 6 26%
Student > Postgraduate 3 13%
Student > Master 2 9%
Other 1 4%
Student > Doctoral Student 1 4%
Other 3 13%
Unknown 7 30%
Readers by discipline Count As %
Medicine and Dentistry 10 43%
Agricultural and Biological Sciences 2 9%
Immunology and Microbiology 2 9%
Veterinary Science and Veterinary Medicine 1 4%
Materials Science 1 4%
Other 0 0%
Unknown 7 30%